Did Lyme disease come from a laboratory?

The market strongly favors that Lyme disease did not come from a laboratory.

Current market probabilities indicate a low likelihood that Lyme disease originated from a laboratory, with 95.13% of participants believing otherwise. The Pulse AI also reflects a similar sentiment, though with a slightly higher probability for the laboratory origin. This suggests a consensus among participants that the natural origins of Lyme disease are more credible.

• 1 Market probability shows strong skepticism towards laboratory origin.
• 2 Pulse AI indicates a slightly higher probability for laboratory involvement.
• 3 Confidence level is moderate at 45/100, suggesting some uncertainty.
• 4 The edge of 3.5 indicates the market is fairly priced based on current data.
• 5 Time to expiry is extensive, allowing for potential shifts in sentiment.